Neuble AI Co.

, Ltd., Ltd. is focused on integrating artificial intelligence with computed tomography to improve diagnostic accuracy.Neuble specializes in advanced medical AI solutions that integrate artificial intelligence with computed tomography (CT) imaging to deliver brain information with precision comparable to magnetic resonance imaging (MRI). The company’s core offerings focus on enhancing the diagnostic capabilities of CT scans, aiming to provide detailed, high-resolution brain analysis in a fraction of the time traditionally required for MRI scans. These products target healthcare institutions and radiology centers seeking efficient diagnostic tools that improve patient outcomes by reducing wait times and increasing diagnostic accuracy.Neuble generates revenue through direct sales of its AI-enhanced CT imaging solutions and associated software services to healthcare providers. Transactions typically occur on a business-to-business (B2B) model, where hospitals and clinics purchase the technology as part of their diagnostic imaging offerings. This may involve one-time purchases or subscription-based models for ongoing access to software updates and support services. The flagship product, which integrates AI capabilities into standard CT imaging equipment, is expected to attract significant interest due to its potential to streamline diagnostic processes and improve clinical decision-making., Ltd.

1. Seed

   Jul 16, 2026

   Amount

   $0.3M

   Investors

   Locked